Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients
Response to Schindhelm et al.
- Christoph Stettler, MD12,
- Matthias Stahl, MD3,
- Sabin Allemann, PHD12,
- Peter Diem, MD1,
- Kurt Schmidlin, DMD2,
- Marcel Zwahlen, PHD2,
- Walter Riesen, PHD4,
- Ulrich Keller, MD5 and
- Emanuel Christ, MD1
- 1Division of Endocrinology, Diabetes and Clinical Nutrition, Inselspital and University of Bern, Bern, Switzerland
- 2Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- 3Department of Internal Medicine, Cantonal Hospital, Olten, Switzerland
- 4Institute of Clinical Chemistry, Haematology and Clinical Microbiology & Immunology, Kantonsspital, St. Gallen, Switzerland
- 5Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital, Basel, Switzerland
- Corresponding author: Christoph Stettler, christoph.stettler{at}insel.ch
We thank Schindhelm et al. (1) for their highly valuable and important comment referring to our study assessing the association of 1,5-anhydroglucitol (1,5-AG) with 2-h postprandial blood glucose (2). We fully agree with these authors on the importance of impaired renal function as a potential factor modifying the association of 1,5-AG and glucose values (1,3). While patients with frank renal failure were excluded from our study, the impact of …
